{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:06:38Z","timestamp":1758477998902,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.atherosclerosis.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T13:28:52Z","timestamp":1668346132000},"page":"71-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Studies on lipoprotein(a) and outcomes in peripheral arterial disease: One must not compare apples with pears"],"prefix":"10.1016","volume":"363","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2229-1120","authenticated-orcid":false,"given":"Florian","family":"Kronenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCGENETICS.111.961292","article-title":"Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies","volume":"5","author":"Murabito","year":"2012","journal-title":"Circ. Cardiovasc. Genet"},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41591-019-0492-5","article-title":"Genome-wide association study of peripheral artery disease in the Million Veteran Program","volume":"25","author":"Klarin","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/cvr\/cvu107","article-title":"Lipoprotein(a) concentrations, apolipoprotein(a) phenotypes and peripheral arterial disease in three independent cohorts","volume":"103","author":"Laschkolnig","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib4","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehl441","article-title":"Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: edinburgh Artery Study","volume":"28","author":"Tzoulaki","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib6","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","article-title":"Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk","volume":"117","author":"Pradhan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1373\/clinchem.2007.088013","article-title":"Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease","volume":"53","author":"Dieplinger","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2020.11.025","article-title":"Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: the CAVASIC study","volume":"316","author":"Kheirkhah","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2021.11.019","article-title":"High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy","volume":"349","author":"Verwer","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015355","article-title":"Association of serum lipoprotein (a) with the requirement for a peripheral artery operation and the incidence of major adverse cardiovascular events in people with peripheral artery disease","volume":"9","author":"Golledge","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/1526602817728068","article-title":"Usefulness of lipoprotein(a) for predicting clinical outcomes after endovascular therapy for aortoiliac atherosclerotic lesions","volume":"24","author":"Hishikari","year":"2017","journal-title":"J. Endovasc. Ther."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib13","unstructured":"Zierfuss, B., H\u00f6baus, C., Feldscher, A., et al., Lipoprotein(a) and long-term outcome in patients with peripheral artery disease undergoing revascularization, Atherosclerosis. In press."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.jcin.2022.05.050","article-title":"Impact of high lipoprotein(a) levels on clinical outcomes following peripheral endovascular therapy","volume":"15","author":"Tomoi","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/eurjpc\/zwab180","article-title":"Measuring lipoprotein(a): do it without ifs and buts","volume":"29","author":"Kronenberg","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib16","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10157-013-0875-8","article-title":"Causes and consequences of lipoprotein(a) abnormalities in kidney disease","volume":"18","author":"Kronenberg","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","article-title":"Non-genetic influences on lipoprotein(a) concentrations","volume":"349","author":"Enkhmaa","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.atherosclerosis.2020.01.022","article-title":"How many more data is required to give the kidney the attention it deserves? Time to act for the \"Big Five\" of cardiovascular risk","volume":"297","author":"Kronenberg","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.11.007_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2022.04.004","article-title":"Lipoprotein(a): an underestimated inflammatory mastermind","volume":"349","author":"Dzobo","year":"2022","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022015039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022015039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:51:41Z","timestamp":1758156701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915022015039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":20,"alternative-id":["S0021915022015039"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.11.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studies on lipoprotein(a) and outcomes in peripheral arterial disease: One must not compare apples with pears","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.10.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}